Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.
Glewis S, Lingaratnam S, Lee B, Campbell I, IJzerman M, Fagery M, Harris S, Georgiou C, Underhill C, Warren M, Campbell R, Jayawardana M, Silva SSM, Martin JH, Tie J, Alexander M, Michael M.
Glewis S, et al. Among authors: campbell i.
Clin Transl Sci. 2024 Dec;17(12):e70083. doi: 10.1111/cts.70083.
Clin Transl Sci. 2024.
PMID: 39614408
Free PMC article.
Clinical Trial.